US FDA accepts Biologics License Application for Mylan and Biocon’s proposed biosimilar…
The FDA goal date set under the Biosimilar User Fee Act (BsUFA) is October 9, 2017
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.